肠道菌群
代谢组学
氧化三甲胺
生物
代谢组
大麻酚
毛螺菌科
拟杆菌
银杏
微生物学
生物化学
药理学
细菌
医学
16S核糖体RNA
生物信息学
基因
大麻
厚壁菌
三甲胺
遗传学
精神科
作者
Mengxue He,Aiyang Liu,Jiachen Shi,Yong‐Jiang Xu,Yuanfa Liu
标识
DOI:10.1089/can.2022.0331
摘要
Introduction: Cannabidiol (CBD) has important pharmacological activity, which includes antispasmodic, antioxidant, antithrombotic, and antianxiety properties. CBD has been applied as a health supplement to atherosclerosis. However, CBDs effect on gut microbiota and metabolic phenotype is unclear. Materials and Methods: We constructed a high production of cardiovascular risk factors, such as trimethylamine-N-oxide (TMAO) and phenylacetylglutamine (PAGln), in a mouse model using Clostridium sporogenes colonization. We used 16S ribosomal RNA (rRNA) gene sequencing and ultra-high performance liquid chromatography-quadrupole time-of flight mass spectrometry-based metabolomics to evaluate the effect of CBD on gut microbiota and plasma metabolites. Results: CBD decreased the levels of creatine kinase (CK), alanine transaminase (ALT), and low-density lipoprotein cholesterol and markedly increased high-density lipoprotein cholesterol. Furthermore, CBD treatment increased the abundance of beneficial bacteria, which include Lachnospiraceae_NK4A136 and Blautia in the gut, but it decreased the levels of TMAO and PAGln in the plasma. Conclusion: CBD might have beneficial effects for cardiovascular protection.
科研通智能强力驱动
Strongly Powered by AbleSci AI